Monkeypox vaccine producer says enough supplies are available

On May 26, 2022

The producer of monkeypox vaccine said, there is sufficient supplies of the Imvanex shot, available to handle the current outbreak.

Bavarian Nordic is the only company in the world whose monkeypox vaccine has regulatory approval.

According to spokesman Rolf Sass Sorensen, “It is currently possible to produce 30 million doses annually.

“Planning is currently underway for it to be approved in the European Union (EU) is being planned.”

Cases of monkeypox are spreading. The virus usually causes mild symptoms such as rash, fever and pustules, but can also be severe.

The company is based in Denmark and produces the vaccine there, although it was initially developed in the German branch in Martinsried near Munich.

However, the shot is only approved in the U.S., where it is called Jynneos, and Canada.

In Europe, the vaccine has only been approved for smallpox in humans, which is considered extinct.

The vaccine is also being used in Britain but off label without the corresponding approval.

He said the company was receiving many enquiries about the shot but did not state which countries had bought the vaccine or how much.

Vanguard